DalsnaFinance

BofA raises Merck stock price target to $141 on cancer drug potential

Stocks Investing.com UK By Investing.com UK 30 Jun 2026 10:12 1 min read
BofA raises Merck stock price target to $141 on cancer drug potential

BofA raises Merck stock price target to $141 on cancer drug potential  Investing.com UK

BofA raises Merck stock price target to $141 on cancer drug potential Investing.com UK

Read the full story on Investing.com UK → Opens the original article on news.google.com

Summary aggregated from Investing.com UK's public RSS feed. The full reporting belongs to Investing.com UK — please read it on their site.